Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €2.11 EUR
Change Today 0.00 / 0.00%
Volume 0.0
As of 11:39 AM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

ab-biotics sa (ABB) Snapshot

Open
€2.11
Previous Close
€2.11
Day High
€2.11
Day Low
€2.11
52 Week High
04/1/15 - €2.51
52 Week Low
10/16/14 - €1.55
Market Cap
20.2M
Average Volume 10 Days
2.0K
EPS TTM
€-0.16
Shares Outstanding
9.6M
EX-Date
09/23/11
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AB-BIOTICS SA (ABB)

Related News

No related news articles were found.

ab-biotics sa (ABB) Related Businessweek News

No Related Businessweek News Found

ab-biotics sa (ABB) Details

AB-Biotics, S.A. operates in the biotechnology industry in Spain. The company’s marketed products comprise AB-LIFE, a probiotic product, which reduces the risk of cardiovascular disease by normalizing serum lipids, reducing vascular inflammation, and lowering blood pressure; AB-FORTIS, an iron-containing ingredient with a double-coat microencapsulation that allows the fortification of foods with iron without the risk of generating undesirable byproducts comprising oxidized lipids, which are caused by iron-mediated oxidation; and AB-DENTALAC, a probiotic product designed to fight the oral pathogens causing caries, gingivitis, and halitosis or bad breath. Its clinical products include AB-I3.1 that reduces the symptoms and the frequency of gastrointestinal emergencies in patients affected by IBD and IBS; AB-COLIC, which is designed to be orally administered in an oil-based solution, with broad antagonism for pathogens present in breast milk and infant formula; and AB-INTIMUS, a probiotic with ability to adhere to the vaginal epithelium and displace candida infections. The company also offers AB-GINGIBAL designed to enhance gum health in patients suffering from gingivitis; AB-HALITIOSIS that rids the oral cavity of unwanted microorganisms and helps to rebuild microflora in the mouth; AB-ENHANCER, a probiotic alternative; AB-PYLORIOSIS; AB-RADIOBAL, a probiotic formula designed to reduce the incidence of radiotherapy-induced diarrhea; AB-VITAMIN-K; and AB-PROBIOSIS, a functional ingredient. In addition, it provides Neuropharmagen, an analytical test for use in neurology and psychiatry that identifies an appropriate medication for each individual patient by analyzing their DNA; and outsourced research and development solutions to pharmaceutical companies, as well as functional food companies. The company is based in Barcelona, Spain.

ab-biotics sa (ABB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ab-biotics sa (ABB) Key Developments

AB-Biotics SA, Annual General Meeting, Jun 29, 2015

AB-Biotics SA, Annual General Meeting, Jun 29, 2015., at 11:00 Central European Standard Time. Location: Paseo de Gracia No. 19. Agenda: To consider and approval, where applicable, of the annual accounts (balance, account of profit and loss, state of changes in equity, State (of flows of cash and memory) corresponding to the exercise closed to of December 31, 2014, verified by the Auditors of the accounts of the company; to consider and approve, where appropriate, the proposed distribution of the profit for the year 2014; to approve censorship and approval, where appropriate, the social management of the organ of administration; to approve remuneration of the members of the board of directors; to approve authorization to the board of directors for the interpretation, rectify, complement, execution and development of agreements adopted at the meeting, as well as to replace the powers received from the Board, and award powers to raise a public instrument of such agreements; and to consider the other things.

AB Biotics Presents at NewYork BIO 25th Anniversary Conference 2015, May-05-2015 08:30 AM

AB Biotics Presents at NewYork BIO 25th Anniversary Conference 2015, May-05-2015 08:30 AM. Venue: Time Warner Center, New York, United States. Speakers: Carlos de Lecca, CEO.

AB-Biotics SA Presents at BIO-Europe Spring 2015, Mar-09-2015

AB-Biotics SA Presents at BIO-Europe Spring 2015, Mar-09-2015 . Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABB:SM €2.11 EUR 0.00

ABB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ABB.
View Industry Companies
 

Industry Analysis

ABB

Industry Average

Valuation ABB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 7.4x
Price/Book 2.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 6.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AB-BIOTICS SA, please visit www.ab-biotics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.